Pier Mannuccio Mannucci
Overview
Explore the profile of Pier Mannuccio Mannucci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
437
Citations
6823
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Blasi C, Settembrini A, Stafoggia M, Renzi M, Mannucci P
Eur J Intern Med
. 2025 Mar;
PMID: 40057382
No abstract available.
2.
Franchini M, Pasca S, Mengoli C, Focosi D, Mannucci P
Haemophilia
. 2025 Feb;
PMID: 39950390
Background: Prophylaxis with coagulation factor concentrates is the mainstay of treatment in severe hemophilia A and B. Data on bleeding rates in persons with congenital haemophilia B (PwcHB) receiving prophylaxis...
3.
Harari S, Caminati A, Ripamonti L, Marveggio P, Mannucci P
Eur J Intern Med
. 2025 Feb;
PMID: 39904694
No abstract available.
4.
Franchini M, Mannucci P
Semin Thromb Hemost
. 2025 Feb;
PMID: 39904369
Chronic liver disease is a frequently encountered disorder and a major concern worldwide with a complex pathophysiology, which often affects the hemostatic system. Such alterations, which affect both primary and...
5.
Swan D, Turner R, Franchini M, Mannucci P, Thachil J
Lancet Haematol
. 2024 Dec;
12(1):e68-e82.
PMID: 39653046
Air pollution, comprising a variable mixture of gaseous and solid particulate material, represents a serious, unmet, global health issue. The Global Burden of Disease study reported that 12% of all...
6.
Miri S, Rosendaal F, Kavakli K, Eshghi P, Moghaddam S, Scardo S, et al.
Res Pract Thromb Haemost
. 2024 Dec;
8(8):102595.
PMID: 39649130
Background: The SIPPET randomized clinical trial showed that in previously untreated patients (PUPs) with severe hemophilia A, treatment with plasma-derived factor (F)VIII (pdFVIII) within the first 50 exposure days (EDs)...
7.
Di Blasi C, Nobile F, Settembrini A, Stafoggia M, Davoli M, Michelozzi P, et al.
Eur J Intern Med
. 2024 Dec;
132:113-117.
PMID: 39643451
Introduction: The association between air pollution and cardiovascular diseases is well established. However, fewer studies focused on the relationship between air pollution and peripheral artery disease (PAD), notwithstanding that not...
8.
Berger K, ORourke R, Di Minno M, Batorova A, Kavakli K, Mannucci P, et al.
Haematologica
. 2024 Nov;
110(3):673-682.
PMID: 39540229
The treatment landscape for hemophilia continues to rapidly develop, and expectations for future treatment success are high. There is limited information on the challenges of accessing new and innovative therapies....
9.
Najjar-Debbiny R, Nobili A, Mannucci P, Barnett-Griness O, Saliba W, Adir Y, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200908
This retrospective study contrasts the impact of the SARS-CoV-2 pandemic in Lombardy (Italy) and Israel, focusing on mortality, healthcare response, public health measures, and demographics. We analyzed SARS-CoV-2 data from...
10.
Franchini M, Focosi D, Pezzo M, Mannucci P
Semin Thromb Hemost
. 2024 Aug;
51(3):312-321.
PMID: 39151904
Catastrophic thrombosis is a severe condition characterized by a hypercoagulable tendency, leading to multiple thromboembolic events in different blood vessels, usually within a short timeframe. Several conditions have been associated...